15.05
前日終値:
$15.08
開ける:
$15.03
24時間の取引高:
9,609
Relative Volume:
0.09
時価総額:
$209.08M
収益:
$6.67M
当期純損益:
$-47.55M
株価収益率:
-10.03
EPS:
-1.5
ネットキャッシュフロー:
$-17.44M
1週間 パフォーマンス:
+15.24%
1か月 パフォーマンス:
+20.40%
6か月 パフォーマンス:
+2,843%
1年 パフォーマンス:
+2,843%
Crescent Biopharma Inc Stock (CBIO) Company Profile
CBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CBIO
Crescent Biopharma Inc
|
15.05 | 253.08M | 6.67M | -47.55M | -17.44M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | 開始されました | Jefferies | Buy |
| 2025-08-11 | 開始されました | H.C. Wainwright | Buy |
| 2025-07-14 | 開始されました | Wedbush | Outperform |
| 2025-06-25 | 開始されました | Stifel | Buy |
| 2025-03-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-03-11 | 開始されました | Noble Capital Markets | Outperform |
| 2024-07-26 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-22 | 開始されました | CapitalOne | Overweight |
| 2021-11-12 | アップグレード | Jefferies | Hold → Buy |
| 2021-04-29 | 再開されました | Stephens | Overweight |
| 2021-02-10 | 開始されました | Piper Sandler | Overweight |
| 2020-05-21 | 開始されました | Raymond James | Outperform |
| 2019-11-14 | 開始されました | ROTH Capital | Buy |
| 2019-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-08-05 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | ダウングレード | SunTrust | Buy → Hold |
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2019-01-04 | 開始されました | Oppenheimer | Outperform |
| 2018-12-18 | 開始されました | H.C. Wainwright | Buy |
| 2018-02-12 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-12-08 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 開始されました | Chardan Capital Markets | Buy |
| 2017-06-06 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-07-26 | 開始されました | SunTrust | Buy |
| 2016-06-30 | 開始されました | Rodman & Renshaw | Buy |
| 2015-03-17 | 繰り返されました | Stifel | Buy |
すべてを表示
Crescent Biopharma Inc (CBIO) 最新ニュース
Crescent Biopharma Inc (CBIO) - MSN
Crescent Biopharma (NASDAQ:CBIO) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Crescent Biopharma Advances Cancer Therapy Pipeline - MSN
MSN Money - MSN
Is Crescent Biopharma Inc. (GKO0) stock protected from inflationJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
Will Crescent Biopharma Inc. (GKO0) stock recover faster than industryJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickExit Point & AI Powered Buy/Sell Recommendations - newser.com
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stock2025 Top Decliners & Daily Entry Point Alerts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of “Buy” from Analysts - Defense World
Crescent Biopharma (Nasdaq: CBIO) Approves 451,448-Share Inducement Options at $13.02 - Stock Titan
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Hold Rating - Defense World
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetrationEntry Point & Long-Term Safe Return Strategies - newser.com
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stock2025 Price Targets & Community Consensus Picks - newser.com
Can Crescent Biopharma Inc. (GKO0) stock beat analyst consensusBond Market & AI Forecasted Entry and Exit Points - newser.com
Crescent Biopharma to present preclinical data from CR-001 - MSN
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Crescent Biopharma, Inc. (C68.F) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Crescent Biopharma, Inc. (C68.F) Interactive Stock Chart - Yahoo! Finance Canada
Crescent Biopharma: Q3 Earnings Snapshot - theheraldreview.com
Crescent Biopharma Inc expected to post a loss of $2.02 a shareEarnings Preview - TradingView
Crescent Biopharma, Inc. (C68.F) Analyst Ratings, Estimates & Forecasts - Yahoo! Finance Canada
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
[S-8] CRESCENT BIOPHARMA, INC. Employee Benefit Plan Registration | CBIO SEC FilingForm S-8 - Stock Titan
CRESCENT BIOPHARMA, INC. SEC 10-Q Report - TradingView
Crescent Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[8-K] CRESCENT BIOPHARMA, INC. Reports Material Event | CBIO SEC FilingForm 8-K - Stock Titan
Crescent Biopharma Inc (CBIO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):